Agents for the Treatment of Overactive Detrusor. IX. Synthesis and Pharmacological Properties of Metabolites of N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine(FK584) in Human Urine.
作者:Kiyoshi TANIGUCHI、Yasuhiro MIYAO、Katsuhiro YAMANO、Takao YAMAMOTO、Takao TERAI、Takahiro KUSUNOKI、Kazunori TSUBAKI、Youichi SHIOKAWA
DOI:10.1248/cpb.44.1188
日期:——
We synthesized the racemates of five presumed metabolites (1b-f) of (S)-(-)-N-tert-butyl-4, 4-diphenyl-2-cyclopentenylamine hydrochloride (FK584, S(-)-1a), a novel agent for the treatment of overactive detrusor syndrome, in order to confirm the structures of the metabolites and also to evaluate thier inhibitory activity against detrusor contraction. (±)-N-tert-Butyl-4-(4-hydroxyphenyl)- and 4-(4-hydroxy-3-methoxyphenyl)-4-phenyl-2-cyclopenetenyl-amines (1b-e) were synthesized via 5-(4-methoxyphenyl)- and 5-(4-benzyloxy-3-methoxyphenyl)-5-phenyl-2-cyclopenten-1-one (9g, h), respectively. Compounds 1b-f prepared in this study were identical with the metabolites in human urine in gas chromatography-mass specrometry and analytical HPLC. The inhibitory activity of compounds 1b-f against detrusor contraction in vitro induced by electrical field stimulation in guinea-pigs was less potent than that of FK584.
我们合成了 (S)-(-)-N-叔丁基-4, 4-二苯基-2-环戊烯胺盐酸盐 (FK584, S(-)-1a) 的五种推测代谢物 (1b-f) 的外消旋体,用于治疗逼尿肌过度活跃综合征的新型药物,以确认代谢物的结构并评估其对逼尿肌收缩的抑制活性。 (±)-N-叔丁基-4-(4-羟基苯基)-和4-(4-羟基-3-甲氧基苯基)-4-苯基-2-环戊烯基胺(1b-e)通过5-合成(4-甲氧基苯基)-和5-(4-苄氧基-3-甲氧基苯基)-5-苯基-2-环戊烯-1-酮(9g,h)。本研究中制备的化合物 1b-f 在气相色谱-质谱和分析型 HPLC 中与人尿中的代谢物相同。化合物1b-f对豚鼠体外由电场刺激诱导的逼尿肌收缩的抑制活性不如FK584有效。